Loading asset research
Pulse Biosciences Inc Common Stock (DE)
PLSENasdaq · USD · StocksQuote as of · Exchange session not verified$51.56
+3.93%
Today
PLSE
Loading 1D prices…
Market cap
$3.6B
Volume
571.9K
52w high
$58.9052w low
$12.56Company profile
Pulse Biosciences Inc Common Stock (DE)
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
HAYWARD, CA, United States
Employees
116
Fiscal year end
1231
CIK
1625101
Session & valuation
Open$49.46
Previous close$49.61
Day high$53.55
Day low$49.01
30-day avg. volume589.3K
Outstanding shares71.3M
Diluted EPS-$1.08
Latest annual period
P/E (trailing)-47.74
P/E (forward)-43.88
Price / book36.02
Beta1.63
Dividend yield—
Deterministic peer set
Companies with SEC SIC 3841
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| IRTCiRhythm Holdings Inc. Common Stock | $3.7B | $747.1M | -6.02% | -$1.39 | -2.26% | Buy |
| ICUIICU Medical Inc. Common Stock | $3.8B | $2.2B | +0.03% | $0.03 | -1.74% | Buy |
| HTFLHeartflow Inc. Common Stock | $4.3B | $176M | -66.35% | -$3.17 | +2.63% | Buy |
| ATRCAtriCure Inc. Common Stock | $3B | $534.5M | -2.14% | -$0.24 | +3.43% | Buy |
| HAEHaemonetics Corporation Common Stock | $4.9B | $1.3B | +7.29% | $2.05 | +2.96% | Buy |